Pharmacologic and Neuromodulatory Research of Catatonia in Autism

Presenter:
Joshua Ryan Smith, MD

Learning Objectives

At the conclusion of this activity, learners should be able to:

• Recognize catatonia, including hyperactive presentations more common in autistic and pediatric patients 
• Initiate treatment and identify when electroconvulsive therapy is indicated 
• Evaluate emerging evidence that catatonia may involve motor-behavior circuits already vulnerable in autism and other neurodevelopmental disorders 

Target Audience

Physicians, advanced practice providers, nurses, and other healthcare professionals.

Continuing Education Credit

Children’s Hospital Colorado is accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Children’s Hospital Colorado designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure

Consent was obtained by parents and patients for the use of the following videos and pictures 
Some may be distressing, please feel free to step out as needed
Family members were eager to share

MEND Clinic Financial Support from the following industry-sponsored clinical trials in autism 
Janssen, Roche, Axial, Vanda, BMS
I also receive salary support from NICHD (1P50HD103537-01) and NIMH (1R01MH135028-01A1)

All other individuals in control of content, including planners and faculty, have no relevant financial relationships with ineligible companies to disclose.